144 related articles for article (PubMed ID: 10584917)
1. Drugs and uterine motility.
Payton RG; Brucker MC
J Obstet Gynecol Neonatal Nurs; 1999; 28(6):628-38. PubMed ID: 10584917
[TBL] [Abstract][Full Text] [Related]
2. Uterotonics and tocolytics for anesthesiologists.
Sumikura H; Inada E
Curr Opin Anaesthesiol; 2016 Jun; 29(3):282-7. PubMed ID: 26974052
[TBL] [Abstract][Full Text] [Related]
3. [Clinical pharmacology in obstetrics: regulation of the uterus].
Mosler KH; Linka F
Med Klin; 1975 May; 70(18):798-805. PubMed ID: 238096
[No Abstract] [Full Text] [Related]
4. [Physiology and pharmacology of labor pain stimulation and labor pain inhibition].
Hüter J
Ther Umsch; 1969 Aug; 26(8):427-33. PubMed ID: 5355758
[No Abstract] [Full Text] [Related]
5. Application of uterotonics on the basis of regular ultrasonic evaluation of the uterus prevents unnecessary surgical intervention in the postpartum period.
Zubor P; Szunyogh N; Dokus K; Scasny P; Kajo K; Galo S; Biringer K; Krivus S; Danko J
Arch Gynecol Obstet; 2010 Sep; 282(3):261-7. PubMed ID: 19760186
[TBL] [Abstract][Full Text] [Related]
6. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol.
Vallera C; Choi LO; Cha CM; Hong RW
Anesthesiol Clin; 2017 Jun; 35(2):207-219. PubMed ID: 28526143
[TBL] [Abstract][Full Text] [Related]
7. The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.
Weissman A; Tobia RS; Burke YZ; Maxymovski O; Drugan A
J Matern Fetal Neonatal Med; 2017 Feb; 30(3):329-333. PubMed ID: 27030149
[TBL] [Abstract][Full Text] [Related]
8. Uterine electrical activity, oxytocin and labor: translating electrical into mechanical.
Lavie A; Shinar S; Hiersch L; Ashwal E; Yogev Y; Aviram A
Arch Gynecol Obstet; 2018 Jun; 297(6):1405-1413. PubMed ID: 29453654
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of drugs that affect uterine motility.
Sultatos LG
J Nurse Midwifery; 1997; 42(4):367-70. PubMed ID: 9277068
[TBL] [Abstract][Full Text] [Related]
10. Maternal and fetal effects of uterine stimulants and relaxants.
Petrie RH; Danilo P
Diagn Gynecol Obstet; 1981; 3(2):111-7. PubMed ID: 6114825
[TBL] [Abstract][Full Text] [Related]
11. Sublingual nitroglycerin for management of retained placenta.
Bullarbo M; Tjugum J; Ekerhovd E
Int J Gynaecol Obstet; 2005 Dec; 91(3):228-32. PubMed ID: 16226759
[TBL] [Abstract][Full Text] [Related]
12. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity.
Hadar E; Melamed N; Aviram A; Raban O; Saltzer L; Hiersch L; Yogev Y
Am J Obstet Gynecol; 2013 Oct; 209(4):384.e1-7. PubMed ID: 23727522
[TBL] [Abstract][Full Text] [Related]
13. [Regulatory mechanisms of the motility of the non-pregnant uterus (author's transl)].
Fröhlich H
Wien Klin Wochenschr Suppl; 1974; 24():3-28. PubMed ID: 4529582
[No Abstract] [Full Text] [Related]
14. Abdominal electromyography in laboring and non-laboring pregnant women at term and its clinical implications.
Kandil M; Emarh M; Ellakwa H
Arch Gynecol Obstet; 2013 Aug; 288(2):293-7. PubMed ID: 23435723
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of the motility of the human uterus. IV. The effects of oxytocin, methylergometrine, dihydroergotamine and two new oxytocics on the spontaneous motility in different parts of the pregnant and nonpregnant uterus.
SANDBERG F; INGELMAN-SUNDBERG A; LINDGREN L; RYDEN G
J Obstet Gynaecol Br Emp; 1959 Jun; 66():417-23. PubMed ID: 14441363
[No Abstract] [Full Text] [Related]
16. The development and introduction of anti-oxytocic tocolytics.
Lamont RF
BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandins: current therapeutic status in obstetrics.
Liggins GC
Drugs; 1974; 8(3):161-3. PubMed ID: 4434869
[TBL] [Abstract][Full Text] [Related]
18. [The effect of calcium antagonists, partusisten, oxytocin and prostenon on uterine contractile activity in pregnant rats].
Korkhov VV; Abdullaev DN
Eksp Klin Farmakol; 1995; 58(6):40-1. PubMed ID: 8704611
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
[TBL] [Abstract][Full Text] [Related]
20. Second-line uterotonics and the risk of hemorrhage-related morbidity.
Butwick AJ; Carvalho B; Blumenfeld YJ; El-Sayed YY; Nelson LM; Bateman BT
Am J Obstet Gynecol; 2015 May; 212(5):642.e1-7. PubMed ID: 25582104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
